CareRay(SH:688607) Ge Long Hui·2025-12-29 11:12Core Viewpoint - Kangzhong Medical (688607.SH) has announced the conclusion of its fundraising projects and the allocation of surplus funds for operational and R&D purposes [1] Group 1: Fundraising Projects - The company held its 13th (temporary) meeting of the third board on December 29, 2025, to review and approve the conclusion of its initial public offering fundraising projects [1] - The projects concluded include the "Flat Panel Detector Production Base Construction Project" and the "R&D Service Center Construction Project" [1] Group 2: Surplus Fund Allocation - The total amount of surplus fundraising is 73.6495 million yuan (excluding interest and financial income) [1] - Of the total fundraising amount, 35.1485 million yuan is pending payment [1] - The company plans to allocate 30 million yuan to the "Next Generation Flat Panel Detector Design and Manufacturing Technology" R&D project and 43.6495 million yuan to permanently supplement working capital [1]